Cargando…
High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia
BACKGROUND: Acute myeloid leukemia (AML) pertains to a hematologic malignancy with heterogeneous therapeutic responses. Improvements in risk stratification in AML patients are warranted. MicroRNAs have been associated with the pathogenesis of AML. METHODS: To examine the prognostic value of miR-25,...
Autores principales: | Niu, Mingshan, Feng, Yuan, Zhang, Ninghan, Shao, Tingting, Zhang, Huihui, Wang, Rong, Yao, Yao, Yao, Ruosi, Wu, Qingyun, Cao, Jiang, Liu, Xuejiao, Liu, Yubo, Xu, Kailin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505210/ https://www.ncbi.nlm.nih.gov/pubmed/31080363 http://dx.doi.org/10.1186/s12935-019-0843-9 |
Ejemplares similares
-
High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
por: Zhang, Huihui, et al.
Publicado: (2019) -
MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia
por: Niu, Mingshan, et al.
Publicado: (2019) -
MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy
por: Yang, Chen, et al.
Publicado: (2018) -
MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation
por: Wang, Rong, et al.
Publicado: (2020) -
Preclinical evaluation of the ROCK1 inhibitor, GSK269962A, in acute myeloid leukemia
por: Pan, Ting, et al.
Publicado: (2022)